HETEROGENEITY IN REPORTED BASELINE DATA AND VARIABLES FROM OBSERVATIONAL STUDIES IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM A SYSTEMATIC REVIEW

被引：0
|
作者：
Wong, Charlotte
van Oostrom, Joep M.
Bossuyt, Peter
Pittet, Valerie
Hanzel, Jurij
Samaan, Mark A.
Tripathi, Monika
Czuber-Dochan, Wladyslawa
Burisch, Johan M.
Leone, Salvatore
Saldana, Roberto
Baert, Filip J.
Kopylov, Uri
Jaghult, Susanna
Adamina, Michel
Gecse, Krisztina B.
Arebi, Naila
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EP1034
引用
收藏
页码：S1038 / S1039
页数：2
相关论文
共 50 条
  • [41] Probiotics in the Management of Inflammatory Bowel Disease A Systematic Review of Intervention Studies in Adult Patients
    Jonkers, Daisy
    Penders, John
    Masclee, Ad
    Pierik, Marieke
    DRUGS, 2012, 72 (06) : 803 - 823
  • [42] Complementary and alternative therapies in the treatment of inflammatory bowel disease: a systematic review of human studies
    Ng, S. C.
    Tsoi, K. K. F.
    Lam, Y. T.
    Bian, Z. X.
    Lao, L. X.
    Berman, B.
    Che, C. T.
    Sung, J. J. Y.
    Wu, J. C. Y.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 106 - 106
  • [43] A Role for Primary Care Pharmacists in the Management of Inflammatory Bowel Disease? Lessons from Chronic Disease: A Systematic Review
    Prasad, Sharmila S.
    Duncanson, Kerith
    Keely, Simon
    Talley, Nicholas J.
    Kairuz, Therese
    Holtmann, Gerald J.
    Shah, Ayesha
    Walker, Marjorie M.
    PHARMACY, 2020, 8 (04)
  • [44] COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
    Macaluso, Fabio Salvatore
    Orlando, Ambrogio
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (11) : 1222 - 1227
  • [45] Periodontal disease is not associated with risk of inflammatory bowel disease: Results from two prospective cohort studies in the US
    Williams, Katherine M.
    Challa, Prasanna K.
    Lopes, Emily W.
    Burke, Kristin E.
    Ananthakrishnan, Ashwin N.
    Richter, James M.
    Chan, Andrew T.
    Khalili, Hamed
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (10) : 1052 - 1061
  • [46] Gallstone Disease Is Associated With an Increased Risk of Inflammatory Bowel Disease: Results From 3 Prospective Cohort Studies
    Mi, Ningning
    Yang, Man
    Wei, Lina
    Nie, Peng
    Zhan, Shukai
    Nguyen, Long H.
    Smith, Fang Gao
    Acharjee, Animesh
    Liu, Xudong
    Huang, Junjie
    Xia, Bin
    Yuan, Jinqiu
    Meng, Wenbo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (01): : 204 - 212
  • [47] Systematic literature review of observational studies that assess the effectiveness of biologic drugs in the treatment of extra-intestinal manifestations in inflammatory bowel disease
    Peyrin-Biroulet, L.
    Van Assche, G.
    Gomez-Ulloa, D.
    Garcia-Alvarez, L.
    Lara, N.
    Black, C.
    Kachroo, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S409 - S409
  • [48] Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
    Ferraro, Sara
    Leonardi, Luca
    Convertino, Irma
    Blandizzi, Corrado
    Tuccori, Marco
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [49] Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
    Zheng, Dian-yu
    Wang, Yi-nuo
    Huang, Yu-Hong
    Jiang, Min
    Dai, Cong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 126
  • [50] Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies
    Bahnam, Paul
    Hanzel, Jurij
    Ma, Christopher
    Zou, Lily
    Narula, Neeraj
    Singh, Siddharth
    Kahan, Brennan
    Jairath, Vipul
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (03): : 404 - 417
12345